Shan Dong Kexing Bioproducts Co (SHSE:688136) ROE %: -4.12% (As of Mar. 2026)


SHSE:688136 Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
44 GF Score
Price ¥20.96
GF Value ¥23.98
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shan Dong Kexing Bioproducts Co ROE %?

Shan Dong Kexing Bioproducts Co SHSE:688136 -2.19% 44 ROE % is -4.12% as of Mar. 2026. GuruFocus rates SHSE:688136 with a GF Score™ of 44/100 and a GF Value™ of ¥23.98 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,250 Biotechnology companies, Shan Dong Kexing Bioproducts Co ranks better than 85.36% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shan Dong Kexing Bioproducts Co's annualized net income for the quarter that ended in Mar. 2026 was ¥-72 Mil. Shan Dong Kexing Bioproducts Co's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ¥1,739 Mil. Therefore, Shan Dong Kexing Bioproducts Co's annualized ROE % for the quarter that ended in Mar. 2026 was -4.12%.

The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's ROE % or its related term are showing as below:

SHSE:688136' s ROE % Range Over the Past 10 Years
Min: -11.08   Med: 9.19   Max: 27.98
Current: 6.56

During the past 9 years, Shan Dong Kexing Bioproducts Co's highest ROE % was 27.98%. The lowest was -11.08%. And the median was 9.19%.

SHSE:688136's ROE % is ranked better than
85.36% of 1250 companies
in the Biotechnology industry
Industry Median: -38.53 vs SHSE:688136: 6.56

Shan Dong Kexing Bioproducts Co  (SHSE:688136) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-71.748/1739.3725
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-71.748 / 1122.1)*(1122.1 / 3511.9965)*(3511.9965 / 1739.3725)
=Net Margin %*Asset Turnover*Equity Multiplier
=-6.39 %*0.3195*2.0191
=ROA %*Equity Multiplier
=-2.04 %*2.0191
=-4.12 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-71.748/1739.3725
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-71.748 / -103.336) * (-103.336 / -4.7) * (-4.7 / 1122.1) * (1122.1 / 3511.9965) * (3511.9965 / 1739.3725)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6943 * 21.9864 * -0.42 % * 0.3195 * 2.0191
=-4.12 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shan Dong Kexing Bioproducts Co ROE % Related Terms


Shan Dong Kexing Bioproducts Co ROE % Historical Data

* Premium members only.

The historical data trend for Shan Dong Kexing Bioproducts Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shan Dong Kexing Bioproducts Co ROE % Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only 5.16 -4.86 -11.08 1.93 9.19

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.20 13.09 7.28 10.23 -4.12

SHSE:688136 vs VRTX, REGN, ALNY: ROE % Comparison

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shan Dong Kexing Bioproducts Co ROE % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's ROE % distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's ROE % falls into.


SHSE:688136
44GF Score
Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shan Dong Kexing Bioproducts Co ROE % Calculation

Shan Dong Kexing Bioproducts Co's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=155.568/( (1634.909+1750.992)/ 2 )
=155.568/1692.9505
=9.19 %

Shan Dong Kexing Bioproducts Co's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-71.748/( (1750.992+1727.753)/ 2 )
=-71.748/1739.3725
=-4.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -4.12% mean?
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a ROE % of -4.12% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. According to the industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #183 out of 1250 companies in the Biotechnology industry, placing it in the top 14.6%.
Is Shan Dong Kexing Bioproducts Co's ROE % too high?
Shan Dong Kexing Bioproducts Co's current ROE % is -4.12%. Based on the distribution chart, Shan Dong Kexing Bioproducts Co ranks #183 out of 1250 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's ROE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shan Dong Kexing Bioproducts Co ranks #183 out of 1250 companies for ROE %. This places Shan Dong Kexing Bioproducts Co in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Biotechnology company?
A good ROE % depends on the Biotechnology industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. Shan Dong Kexing Bioproducts Co's current ROE % is -4.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.98, compared to a current price of ¥20.96 — trading 12.6% below its estimated fair value. The current ROE % is -4.12%. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current ROE % is -4.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?

Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued. The current stock price of ¥20.96 is trading 12.6% below its estimated GF Value™ of ¥23.98. GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.

Key valuation signals for SHSE:688136:

  • ROE %: -4.12%
  • GF Value™: ¥23.98 vs. price of ¥20.96 (12.6% below fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shan Dong Kexing Bioproducts Co Business Description

Address No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
44GF Score

Get the complete analysis for SHSE:688136

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.96
Price
¥23.98
GF Value